ACRV Stock Summary and Trading Ideas (Acrivon Therapeutics | NASDAQ:ACRV)

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Acrivon Therapeutics trades on the NASDAQ stock market under the symbol ACRV.

As of March 20, 2026, ACRV stock price declined to $1.66 with 413,378 million shares trading.

ACRV has a beta of 2.15, meaning it tends to be more sensitive to market movements. ACRV has a correlation of 0.09 to the broad based SPY ETF.

ACRV has a market cap of $52.38 million. This is considered a Micro Cap stock.

Last quarter Acrivon Therapeutics reported $0 in Revenue and -$.49 earnings per share. This fell short of revenue expectation by $-541,598 and missed earnings estimates by -$.02.

In the last 3 years, ACRV traded as high as $20.07 and as low as $1.05.

The top ETF exchange traded funds that ACRV belongs to (by Net Assets): VTI, VXF, IWC.

ACRV has underperformed the market in the last year with a return of -69.6%, while the SPY ETF gained +15.6%. In the last 3 month period, ACRV fell short of the market, returning -23.1%, while SPY returned -4.7%. However, in the most recent 2 weeks ACRV has outperformed the stock market by returning +3.7%, while SPY returned -4.8%.

ACRV support price is $1.59 and resistance is $1.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACRV shares will trade within this expected range on the day.